Pregabalin as a neuroprotector after spinal cord injury in rats: Biochemical analysis and effect on glial cells

Journal of Korean Medical Science

Volumn 26, Issue 3, 2011, Pages 404-411

  Ha, Kee Yong ^a   Carragee, Eugene ^b   Cheng, Ivan ^b   Kwon, Soon Eok ^a   Kim, Young Hoon ^a  

^a The Catholic University of Korea   (South Korea)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Apoptosis; Astrocytes; Microglia; Pregabalin; Spinal cord injuries

Indexed keywords

4 AMINOBUTYRIC ACID; CASPASE 3; DRUG DERIVATIVE; METHYLPREDNISOLONE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROPROTECTIVE AGENT; PREGABALIN; PROTEIN BCL 2;

ANIMAL; APOPTOSIS; ARTICLE; ASTROCYTE; BODY WEIGHT; CELL PROLIFERATION; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENETICS; GLIA; HINDLIMB; INFLAMMATION; MALE; MICROGLIA; MOTOR ACTIVITY; PARALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; RAT; SPINAL CORD INJURY; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; ASTROCYTES; BLOTTING, WESTERN; BODY WEIGHT; CASPASE 3; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION; HINDLIMB; INFLAMMATION; MALE; METHYLPREDNISOLONE; MICROGLIA; MOTOR ACTIVITY; NEUROGLIA; NEUROPROTECTIVE AGENTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PARALYSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES;

EID: 79953764725     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2011.26.3.404     Document Type: Article

References (30)

1. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 2004; 4: 451-64.
2. Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB, Dumont AS. Acute spinal cord injury, Part I: pathophysiologic mechanisms. Clin Neuropharmacol 2001; 24: 254-64.
3. Fehlings MG, Baptiste DC. Current status of clinical trials for acute spinal cord injury. Injury 2005; 36 Suppl 2: B113-22.
4. Rowland JW, Hawryluk GW, Kwon B, Fehlings MG. Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg Focus 2008; 25: E2.
5. Zhang Y, Bhavnani BR. Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release. BMC Neurosci 2005; 6: 13.
6. Xu GY, Liu S, Hughes MG, McAdoo DJ. Glutamate-induced losses of oligodendrocytes and neurons and activation of caspase-3 in the rat spinal cord. Neuroscience 2008; 153: 1034-47.
7. Globus MY, Alonso O, Dietrich WD, Busto R, Ginsberg MD. Glutamate release and free radical production following brain injury: effects of posttraumatic hypothermia. J Neurochem 1995; 65: 1704-11.
8. Park E, Velumian AA, Fehlings MG. The role of excitotoxicity in secondary mechanisms of spinal cord injury: a review with an emphasis on the implications for white matter degeneration. J Neurotrauma 2004; 21: 754-74.
9. Káradóttir R, Cavelier P, Bergersen LH, Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005; 438: 1162-6.
10. Joshi I, Taylor CP. Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice. Eur J Pharmacol 2006; 553: 82-8.
11. Tassone DM, Boyce E, Guyer J, Nuzum D. Pregabalin: a novel gammaaminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders. Clin Ther 2007; 29: 26-48.
12. Fehrenbacher JC, Taylor CP, Vasko MR. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C. Pain 2003; 105: 133-41.
13. Million M, Wang L, Adelson DW, Roman F, Diop L, Taché Y. Pregabalin decreases visceral pain and prevents spinal neuronal activation in rats. Gut 2007; 56: 1482-4.
14. Ha KY, Kim YH, Rhyu KW, Kwon SE. Pregabalin as a neuroprotector after spinal cord injury in rats. Eur Spine J 2008; 17: 864-72.
15. Keane RW, Kraydieh S, Lotocki G, Bethea JR, Krajewski S, Reed JC, Dietrich WD. Apoptotic and anti-apoptotic mechanisms following spinal cord injury. J Neuropathol Exp Neurol 2001; 60: 422-9.
16. Citron BA, Arnold PM, Haynes NG, Ameenuddin S, Farooque M, Santacruz K, Festoff BW. Neuroprotective effects of caspase-3 inhibition on functional recovery and tissue sparing after acute spinal cord injury. Spine (Phila Pa 1976) 2008; 33: 2269-77.
17. Horiuchi H, Ogata T, Morino T, Chuai M, Yamamoto H. Continuous intrathecal infusion of SB203580, a selective inhibitor of p38 mitogen-activated protein kinase, reduces the damage of hind-limb function after thoracic spinal cord injury in rat. Neurosci Res 2003; 47: 209-17.
18. Guo G, Bhat NR. p38alpha MAP kinase mediates hypoxia-induced motor neuron cell death: a potential target of minocycline's neuroprotective action. Neurochem Res 2007; 32: 2160-6.
19. Genovese T, Esposito E, Mazzon E, Muià C, Di Paola R, Meli R, Bramanti P, Cuzzocrea S. Evidence for the role of mitogen-activated protein kinase signaling pathways in the development of spinal cord injury. J Pharmacol Exp Ther 2008; 325: 100-14.
20. Gale K, Kerasidis H, Wrathall JR. Spinal cord contusion in the rat; behavioral analysis of functional neurologic impairment. Exp Neurol 1985; 88: 123-34.
21. Austin JW, Fehlings MG. Molecular mechanisms of Fas-mediated cell death in oligodendrocytes. J Neurotrauma 2008; 25: 411-26.
22. Obata K, Yamanaka H, Kobayashi K, Dai Y, Mizushima T, Katsura H, Fukuoka T, Tokunaga A, Noguchi K. Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation. J Neurosci 2004; 24: 10211-22.
23. Nakahara S, Yone K, Sakou T, Wada S, Nagamine T, Niiyama T, Ichijo H. Induction of apoptosis signal regulating kinase 1 (ASK1) after spinal cord injury in rats: possible involvement of ASK1-JNK and -p38 pathways in neuronal apoptosis. J Neuropathol Exp Neurol 1999; 58: 442-50.
24. Kwak EK, Kim JW, Kang KS, Lee YH, Hua QH, Park TI, Park JY, Sohn YK. The role of inducible nitric oxide synthase following spinal cord injury in rat. J Korean Med Sci 2005; 20: 663-9.
25. Anderson CM, Swanson RA. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000; 32: 1-14.
26. Williams A, Piaton G, Lubetzki C. Astrocytes-friends or foes in multiple sclerosis? Glia 2007; 55: 1300-12.
27. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 2004; 24: 2143-55.
28. Barritt AW, Davies M, Marchand F, Hartley R, Grist J, Yip P, McMahon SB, Bradbury EJ. Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J Neurosci 2006; 26: 10856-67.
29. Buffo A, Rolando C, Ceruti S. Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. Biochem Pharmacol 2010; 79: 77-89.
30. Rosenstein JM, Krum JM. New roles for VEGF in nervous tissue-beyond blood vessels. Exp Neurol 2004; 187: 246-53.